UNSPSC 51381508: Tolmetin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H15NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D8K2JPN18B, chemically known as 1h-pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)- but generally known as tolmetin, which bears US NIH Compound Identifier 5509. European Medicines Agency schedules Tolmetin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11162MIG.

UNSPSC 51381508 Tolmetin, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities posted under this code solicit naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which are tolmetin, a nonsteroidal anti-inflammatory drug. The mismatch suggests a coding or tagging error in the source records rather than active procurement of tolmetin itself at the state and local level.

The issuing bodies in the recent opportunities represent state health agencies and cooperative purchasing vehicles: Seminole County, Florida (a county health procurement); the Texas Health and Human Services Commission (a state health department); and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), which serves multiple state and local participants including Oregon. Geographic activity spans Florida, Texas, and Minnesota. Representative solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription capabilities; and MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) for generic pharmaceuticals and OTC products through authorized wholesalers. The code shows little relevant recent activity for tolmetin specifically; procurement under this code number appears driven by state and local demand for controlled-substance management tools and broad-spectrum generic pharmaceutical supply rather than this single anti-inflammatory agent.